Vitalii Vodolazskyi / Shutterstock.com
24 April 2025NewsAmericasMuireann Bolger

Fed Circ: Generic doesn’t infringe Metacel MS drug

Case looked at whether generic treatment infringes ‘fridge temperature limitation method’ | Ruling underscores importance of clear labelling in drug patent infringement suits.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Europe
22 April 2025   Gene editing company ToolGen “seeks fair licensing agreement” for alleged infringement by rival | High-value sickle cell treatment CASGEVY was “born from ToolGen’s proprietary CRISPR RNP tech” says complaint | Potter Clarkson instructed.
Big Pharma
17 April 2025   Massachusetts lawsuit claims subsidiary of UK pharma company unlawfully re-patented eculizumab, resulting in overpayments of more than $2 billion.
Americas
14 April 2025   Texas company launches sweeping lawsuits against five major players, alleging infringement of medical device patents tied to legacy Sanofi-Aventis technologies | Cases put billions in revenue and key drug delivery products in the spotlight.

More on this story

Europe
22 April 2025   Gene editing company ToolGen “seeks fair licensing agreement” for alleged infringement by rival | High-value sickle cell treatment CASGEVY was “born from ToolGen’s proprietary CRISPR RNP tech” says complaint | Potter Clarkson instructed.
Big Pharma
17 April 2025   Massachusetts lawsuit claims subsidiary of UK pharma company unlawfully re-patented eculizumab, resulting in overpayments of more than $2 billion.
Americas
14 April 2025   Texas company launches sweeping lawsuits against five major players, alleging infringement of medical device patents tied to legacy Sanofi-Aventis technologies | Cases put billions in revenue and key drug delivery products in the spotlight.

More on this story

Europe
22 April 2025   Gene editing company ToolGen “seeks fair licensing agreement” for alleged infringement by rival | High-value sickle cell treatment CASGEVY was “born from ToolGen’s proprietary CRISPR RNP tech” says complaint | Potter Clarkson instructed.
Big Pharma
17 April 2025   Massachusetts lawsuit claims subsidiary of UK pharma company unlawfully re-patented eculizumab, resulting in overpayments of more than $2 billion.
Americas
14 April 2025   Texas company launches sweeping lawsuits against five major players, alleging infringement of medical device patents tied to legacy Sanofi-Aventis technologies | Cases put billions in revenue and key drug delivery products in the spotlight.